St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 108   

Articles published

STJ 74.06 +0.37 (0.50%)
price chart
St. Jude Medical Completes Acquisition of Spinal Modulation, Inc.
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has completed the acquisition of Spinal Modulation, Inc., developer of the Axium™ Neurostimulator System.
St. Jude Medical Receives New Coverage from Analysts at Evercore ISI (STJ)
Finally, analysts at Deutsche Bank raised their price target on shares of St. Jude Medical from $74.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, April 23rd. Two research analysts have rated the stock with a sell ...
St. Jude Medical (STJ) Stock Coverage Initiated at Evercore ISI  TheStreet.com
Notable Session Mover: St. Jude Medical, Inc. (NYSE:STJ)  Vanguard Tribune
St. Jude Medical Announces Intent to Acquire Spinal Modulation, Inc.
Once complete, the acquisition of Spinal Modulation, Inc. will further support St. Jude Medical's mission to help physicians tailor treatment to a patient's chronic pain condition to achieve superior outcomes.
St. Jude Medical (STJ) to Acquire Spinal Modulation in $175M + Milestones Deal  StreetInsider.com
St. Jude Medical Is Acquiring Spinal Modulation for $215M  Medical Device and Diagnostics Industry
Insider Deal: St. Jude Medical, Inc. (NYSE:STJ)'s director Barbara Hill Sold ...
St. Jude Medical, Inc. (NYSE:STJ) 74.27 -0.47 -0.63% director and an insider Barbara Hill a few days ago sold 3,229 company shares having a total value $229,711 at an avg stock price per share of $71.1.
St. Jude Medical Announces Dividend for Second Quarter of Fiscal Year 2015  MarketWatch
St. Jude Medical Announces Canadian Launch and First Implant of the Prodigy ...
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced Health Canada approval and first implant in Canada of its Prodigy™ Chronic Pain System with Burst technology.
St. Jude Medical Presents Data on Quadripolar Technology - Analyst Blog
Presented at the session was data from a study which was conducted to compare St. Jude Medical's Quartet LV lead with a standard bipolar pacing lead.
Data Shows Improved Outcomes for Patients With St. Jude Medical Quadripolar ...  Stockhouse
New Outcomes and Cost Data Further Supports St. Jude Medical Leadership in ...
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the presentation of important data around its SJM™ Quadra CRT System during the Heart Rhythm Society's (HRS) 36th annual scientific sessions.
Market Update: St. Jude Medical Inc (NYSE:STJ) - New Outcomes and Cost Data ...  Jutia Group
The President - Americas of St. Jude Medical, Inc. (NYSE:STJ), Joel Becker ...
Joel Becker, President - Americas of St. Jude Medical, Inc. (NYSE:STJ) 74.46 -0.12 -0.16% is the insider, our financial writers want to reveal transactions for.
St. Jude Medical CMO Lisa Andrade Sells 5000 Shares (STJ)  Dakota Financial News
St. Jude Medical VP Sells $264347.58 in Stock (STJ)  sleekmoney
Analyst Views: St. Jude Medical, Inc. (NYSE:STJ)
Based on analyst estimates, St. Jude Medical, Inc. (NYSE:STJ) is expected to post current fiscal quarter earnings per share of $0.99.
Inexpensive St. Jude Medical Keeps Rewarding Shareholders (STJ)  Seeking Alpha
Stock in Focus - St. Jude Medical, Inc. (NYSE:STJ)  Vanguard Tribune
Stocks Taking Sector High- STMicroelectronics NV (NYSE:STM), St. Jude ...
St. Jude Medical Inc. (NYSE:STJ) reported that preliminary results from the ILUMIEN I trial as well as final results from the ILUMIEN II clinical study.